Functional differences between dendritic cells derived from CD34+ bone marrow and peripheral blood stem cells

Haematologica

Volumn 85, Issue 4, 2000, Pages 352-355

  Servida, Federica ^a   Soligo, Davide ^a,b   Deliliers, Giorgio Lambertenghi ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Antigen uptake; CD34+ cells; Dendritic cells; TFN

Indexed keywords

CD34 ANTIGEN; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MIXED LYMPHOCYTE REACTION;

ANTIGENS, CD34; BONE MARROW CELLS; CELL LINEAGE; DENDRITIC CELLS; DEXTRANS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034074269     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Aglietta M, Bertolini F, Carlo-Stella C, et al. Ex vivo expansion of hematopoietic cells and their clinical use. Haematologica 1998; 83:824-48.
2. Strunk D, Rappersberger K, Egger C, et al. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitors cells. Blood 1996; 87:1292-302.
3. Soligo D, Lambertenghi Deliliers G, Quirici N, Servida F, Caneva L, Lamorte G. Expansion of dendritic cells derived from human CD34+ cells in static and continuous perfusion cultures. Br J Haematol 1998; 101: 352-63.
4. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994; 179: 1109-18.
5. Winzler C, Rovere P, Rescigno M, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997; 185: 317-28.
6. Santiago-Schwarz F, McCarthy M, Tucci J, Carsons SE. Neutralization of tumor necrosis factor activity shortly after the onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway. Blood 1998; 92:745-55.
7. Chen B, Shi Y, Smith JD, Choi D, Geiger JD, Mulé JJ. The role of tumor necrosis factor a in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro. Blood 1998; 91: 4652-61.
8. Herbst B, Köhler G, Mackensen A, Veelken H, Mertelsmann R, Lindemann A. CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis. Br J Haematol 1997; 99:490-9.
9. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996; 19:1518-20.
10. Chischportich C, Bagnis C, Galindo R, Mannoni P. Expression of the nls-Lacz gene in dendritic cells derived from retrovirally transduced peripheral blood CD34+ cells. Haematologica 1999; 84:195-203.
11. Aicher A, Westermann J, Cayeux S, et al. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp Hematol 1997; 25:39-44.
12. Mortarini R, Anichini A, Di Nicola M, et al. Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors. Cancer Res 1997; 57:5534-41.
13. Luft T, Pang KC, Thomas E, et al. A serum-free culture model for studying the differentiation of human dendritic cells from adult CD34+ progenitor cells. Exp Hematol 1998; 26:489-500.
14. Di Nicola M, Longoni P, Magni M, Gianni AM. The influence of interleukin (IL)-4 and IL-13 on human dendritic cell differentiation from CD34+ progenitor cells: the importance of the source of serum. Exp Hematol 1999; 27:386-7.